Furthermore, p53 mutations, characteristic of nonepithelioid MPM, were also 40% higher than that expected in the nonsquamous NSCLC expansion cohort and may also affect FLT PET-CT–based imaging.29 Here, TP53 is linked to non-small cell lung carcinoma.